These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1396 related articles for article (PubMed ID: 11869942)

  • 1. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation.
    Diaz MA; Vicent MG; Prudencio M; Rodriguez F; Marin C; Serrano A; Sevilla J; Casado J; Madero L
    Haematologica; 2002 Mar; 87(3):292-8. PubMed ID: 11869942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the intensive care unit in children undergoing bone marrow transplantation with life-threatening complications.
    Díaz de Heredia C; Moreno A; Olivé T; Iglesias J; Ortega JJ
    Bone Marrow Transplant; 1999 Jul; 24(2):163-8. PubMed ID: 10455344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children.
    Schneider DT; Lemburg P; Sprock I; Heying R; Göbel U; Nürnberger W
    Bone Marrow Transplant; 2000 May; 25(10):1079-86. PubMed ID: 10828869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of child recipients of hematopoietic stem cell transplantation requiring intensive care.
    Lamas A; Otheo E; Ros P; Vázquez JL; Maldonado MS; Muñoz A; Martos I
    Intensive Care Med; 2003 Jan; 29(1):91-6. PubMed ID: 12528028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports.
    Pène F; Aubron C; Azoulay E; Blot F; Thiéry G; Raynard B; Schlemmer B; Nitenberg G; Buzyn A; Arnaud P; Socié G; Mira JP
    J Clin Oncol; 2006 Feb; 24(4):643-9. PubMed ID: 16380411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of children requiring admission to an intensive care unit after bone marrow transplantation.
    Jacobe SJ; Hassan A; Veys P; Mok Q
    Crit Care Med; 2003 May; 31(5):1299-305. PubMed ID: 12771594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in children requiring admission to an intensive care unit after hematopoietic stem cell transplant.
    Cheuk DK; Ha SY; Lee SL; Chan GC; Tsoi NS; Lau YL
    Hematol Oncol; 2004 Mar; 22(1):1-9. PubMed ID: 15152366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of oncology patients admitted to the paediatric intensive care unit of a general children's hospital - a single center analysis.
    Haase R; Lieser U; Kramm C; Stiefel M; Vilser C; Bernig T; Merkel N; Mauz-Körholz C; Körholz D
    Klin Padiatr; 2011 May; 223(3):142-6. PubMed ID: 21567369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unrelated cord blood transplant experience by the pediatric blood and marrow transplant consortium.
    Yu LC; Wall DA; Sandler E; Chan KW; Grayson G; Kletzel M
    Pediatr Hematol Oncol; 2001 Jun; 18(4):235-45. PubMed ID: 11400647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
    Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive Care Unit Admissions Among Children After Hematopoietic Stem Cell Transplantation: Incidence, Outcome, and Prognostic Factors.
    Fernández-García M; Gonzalez-Vicent M; Mastro-Martinez I; Serrano A; Diaz MA
    J Pediatr Hematol Oncol; 2015 Oct; 37(7):529-35. PubMed ID: 26241722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
    Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
    Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary failure of platelet recovery after hematopoietic stem cell transplantation.
    Bruno B; Gooley T; Sullivan KM; Davis C; Bensinger WI; Storb R; Nash RA
    Biol Blood Marrow Transplant; 2001; 7(3):154-62. PubMed ID: 11302549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in outcomes (1996-2004) for pediatric oncology and hematopoietic stem cell transplant patients requiring invasive mechanical ventilation.
    Tamburro RF; Barfield RC; Shaffer ML; Rajasekaran S; Woodard P; Morrison RR; Howard SC; Fiser RT; Schmidt JE; Sillos EM
    Pediatr Crit Care Med; 2008 May; 9(3):270-7. PubMed ID: 18446105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
    de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.